1. Home
  2. HFBL vs PLRX Comparison

HFBL vs PLRX Comparison

Compare HFBL & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Federal Bancorp Inc. of Louisiana

HFBL

Home Federal Bancorp Inc. of Louisiana

N/A

Current Price

$22.37

Market Cap

70.0M

Sector

Finance

ML Signal

N/A

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

N/A

Current Price

$0.82

Market Cap

61.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HFBL
PLRX
Founded
1924
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.0M
61.1M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
HFBL
PLRX
Price
$22.37
$0.82
Analyst Decision
Hold
Analyst Count
0
6
Target Price
N/A
★ $2.67
AVG Volume (30 Days)
3.7K
★ 325.3K
Earning Date
10-27-2026
11-20-2026
Dividend Yield
★ 2.61%
N/A
EPS Growth
★ 60.32
29.97
EPS
★ 2.02
N/A
Revenue
★ $1,694,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.06
★ N/A
Revenue Growth
★ 30.01
N/A
52 Week Low
$14.47
$0.80
52 Week High
$28.00
$1.82

Technical Indicators

Market Signals
Indicator
HFBL
PLRX
Relative Strength Index (RSI) 44.16 31.32
Support Level $21.08 N/A
Resistance Level $23.87 $0.90
Average True Range (ATR) 0.81 0.04
MACD -0.01 0.00
Stochastic Oscillator 47.08 8.65

Price Performance

Historical Comparison
HFBL
PLRX

About HFBL Home Federal Bancorp Inc. of Louisiana

Home Federal Bancorp Inc of louisiana operates as a bank holding company. Through its subsidiary, a federally chartered stock savings bank, it provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial, and multi-family segments. The company also invests in securities held-to-maturity and securities available for sale.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: